Javascript must be enabled to continue!
Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
View through CrossRef
Abstract
Study Objectives
Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness. However, as oxytocin can attenuate stress, reduce activity, and elicit anxiolysis, oxytocin might also prime the brain for rest, and promote sleep. At present, little research has comprehensively characterized the neuropsychopharmacology of oxytocin-induced effects on sleep–wake behavior and no reconciliation of these two competing hypotheses has been proposed.
Methods
This study explored the effects of oxytocin on sleep–wake outcomes using radiotelemetry-based polysomnography in adult male and female Wistar rats. Oxytocin was administered via intraperitoneal (i.p.; 0.1, 0.3 and 1 mg·kg−1) and intranasal (i.n.; 0.06, 1, 3 mg·kg−1) routes. Caffeine (i.p. and i.n.; 10 mg·kg−1) was administered as a wake-promoting positive control. To ascertain mechanism of action, pretreatment experiments with the oxytocin receptor (OXTR) antagonist L-368,899 (i.p.; 5 mg·kg−1) followed by oxytocin (i.p.; 1 mg·kg−1) were also conducted.
Results
In both male and female rats, i.p. oxytocin promoted quiet wakefulness at the cost of suppressing active wakefulness, non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Several i.p. oxytocin-induced sleep–wake effects were mediated by OXTR binding. In contrast, i.n. oxytocin did not alter most sleep–wake outcomes at any dose tested. Both i.p. and i.n. caffeine demonstrated wake-promoting effects.
Conclusions
These findings help reconcile competing hypotheses of oxytocin-induced effects on sleep–wake behavior: i.p. oxytocin promotes quiet wakefulness—a state of restful environmental awareness compatible with both oxytocin’s anxiolytic effects and its enhancement of processing complex stimuli.
Oxford University Press (OUP)
Title: Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
Description:
Abstract
Study Objectives
Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness.
Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness.
However, as oxytocin can attenuate stress, reduce activity, and elicit anxiolysis, oxytocin might also prime the brain for rest, and promote sleep.
At present, little research has comprehensively characterized the neuropsychopharmacology of oxytocin-induced effects on sleep–wake behavior and no reconciliation of these two competing hypotheses has been proposed.
Methods
This study explored the effects of oxytocin on sleep–wake outcomes using radiotelemetry-based polysomnography in adult male and female Wistar rats.
Oxytocin was administered via intraperitoneal (i.
p.
; 0.
1, 0.
3 and 1 mg·kg−1) and intranasal (i.
n.
; 0.
06, 1, 3 mg·kg−1) routes.
Caffeine (i.
p.
and i.
n.
; 10 mg·kg−1) was administered as a wake-promoting positive control.
To ascertain mechanism of action, pretreatment experiments with the oxytocin receptor (OXTR) antagonist L-368,899 (i.
p.
; 5 mg·kg−1) followed by oxytocin (i.
p.
; 1 mg·kg−1) were also conducted.
Results
In both male and female rats, i.
p.
oxytocin promoted quiet wakefulness at the cost of suppressing active wakefulness, non-rapid eye movement (NREM) and rapid eye movement (REM) sleep.
Several i.
p.
oxytocin-induced sleep–wake effects were mediated by OXTR binding.
In contrast, i.
n.
oxytocin did not alter most sleep–wake outcomes at any dose tested.
Both i.
p.
and i.
n.
caffeine demonstrated wake-promoting effects.
Conclusions
These findings help reconcile competing hypotheses of oxytocin-induced effects on sleep–wake behavior: i.
p.
oxytocin promotes quiet wakefulness—a state of restful environmental awareness compatible with both oxytocin’s anxiolytic effects and its enhancement of processing complex stimuli.
Related Results
024 Quiescent Wakefulness: Characterising the Impact of Oxytocin on Sleep-Wake Behaviour in Male and Female Rats
024 Quiescent Wakefulness: Characterising the Impact of Oxytocin on Sleep-Wake Behaviour in Male and Female Rats
Abstract
Introduction
Oxytocin is a versatile hypothalamic neuropeptide involved in diverse neurobehavioural processes. Since ox...
Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
AbstractIntroductionExogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioural processes, including sleep and wakefulness. Since oxyto...
Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events
Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events
Oxytocin is released within the supraoptic nucleus during parturition and suckling. During suckling, such release is important in positive feedback stimulation of oxytocin neurons....
A Personalized and Adaptive Distribution Classification of Actigraphy Segments into Sleep-Wake States
A Personalized and Adaptive Distribution Classification of Actigraphy Segments into Sleep-Wake States
Abstract
Wearable actimeters have the potential to greatly improve our understanding sleep in natural environments and in long-term experiments. Current technologie...
0108 Brief Periods of Sleep and Quiet Rest Equivalently Benefit Memory Consolidation
0108 Brief Periods of Sleep and Quiet Rest Equivalently Benefit Memory Consolidation
Abstract
Introduction
Past research has demonstrated that sleep benefits the consolidation of memories. However, more recent stu...
Fear memory-triggered sleep disruption: insights from ventral hippocampus-basolateral amygdala manipulation
Fear memory-triggered sleep disruption: insights from ventral hippocampus-basolateral amygdala manipulation
Abstract
Study Objectives
A daytime fearful experience may cause sleep disturbances in the following nights, but the unde...
Comparison of the Effectiveness of 5 IU Oxytocin Bolus and 20 IU Infusion on Uterine Contraction and Hemodynamic Response in Caesarean Section
Comparison of the Effectiveness of 5 IU Oxytocin Bolus and 20 IU Infusion on Uterine Contraction and Hemodynamic Response in Caesarean Section
Uterine atonic can result in postpartum hemorrhage, gravid hysterectomy andmaternal mortality. Oxytocin is the most commonly used agent for the preventionand treatment of atonic ut...
Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women
Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women
Objective
To test binding affinities for, and inhibitory effects on, myometrium of some oxytocin and vasopressin antagonists with respect to their therapeutic potential.Desig...

